Workflow
生物股份(600201) - 2024 Q4 - 年度业绩预告
JINYUJINYU(SH:600201)2025-01-17 11:50

Financial Performance Forecast - The company expects a net profit attributable to shareholders for 2024 to be between 103.72 million and 123.08 million yuan, a decrease of 56.61% to 63.43% compared to the previous year[2]. - The net profit after deducting non-recurring gains and losses is projected to be between 48.40 million and 67.76 million yuan, representing a decline of 73.37% to 80.98% year-on-year[3]. - In 2023, the net profit attributable to shareholders was 283.63 million yuan, with a net profit of 254.46 million yuan after deducting non-recurring gains and losses[5]. - The performance forecast is preliminary and has not been audited by an accounting firm[4]. - Investors are advised to pay attention to investment risks as the forecast data is subject to change upon the release of the audited annual report[8]. Factors Affecting Performance - The decline in performance is attributed to the cyclical nature of the breeding industry, increased competition, and a drop in product prices and gross margins[6]. Company Strategy and Resilience - The company continues to invest heavily in R&D to address market uncertainties and enhance efficiency through technological innovation[6]. - The company maintains a stable production and operation despite market challenges, demonstrating resilience[6].